
This folder contains code for reproducing results and figures in Burrell et al, Results of the window-of-opportunity PIONEER trial evaluating addition of the progesterone receptor (PR) agonist megestrol to letrozole for early-stage estrogen receptor (ER) positive breast cancer: exploiting ER-PR interaction, Nature Cancer, 2025.
Detailed methods and also trial design can be found in Methods and Supplementary information of this paper.
